Testing effectiveness (Phase 2)Study completedNCT01082939
What this trial is testing
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 80